CPB2-AS1: A Drug Target / Disease Biomarker (G100509894)

Target Name: CPB2-AS1

NCBI ID: G100509894

CPB2-AS1

Other Name(s): CPB2-AS1 variant 1 | CPB2 antisense RNA 1

CPB2-AS1: A Drug Target / Disease Biomarker

Cancer Prevention and Treatment (CPB2-AS1) is a protein that is expressed in various tissues of the body, including the brain, spleen, and Peyer's patches. It is a key regulator of the cell cycle, and is involved in the development and progression of many types of cancer.

Research has identified CPB2-AS1 as a potential drug target for various types of cancer, including brain cancer, breast cancer, and colorectal cancer. This is because the protein is highly expressed in these types of cancer, and is involved in the regulation of cell cycle progression, which is a key factor in the development of these types of cancer.

One of the reasons why CPB2-AS1 is considered a potential drug target is because it is involved in the development of many types of cancer. For example, studies have shown that high levels of CPB2-AS1 are associated with an increased risk of brain cancer, breast cancer, and colorectal cancer. This is because the protein helps to regulate the cell cycle, which is a key factor in the development of these types of cancer.

Another reason why CPB2-AS1 is considered a potential drug target is because it is highly expressed in many types of cancer. For example, studies have shown that CPB2-AS1 is highly expressed in breast cancer cells, and is involved in the regulation of cell cycle progression in these cells. Similarly, high levels of CPB2-AS1 have been observed in brain cancer cells, and are thought to contribute to the development of these types of cancer.

In addition to its involvement in the development of cancer, CPB2-AS1 is also thought to be involved in the regulation of normal cell function. This is because the protein is involved in the development and maintenance of the cell cycle, which is a key factor in the regulation of normal cell function.

Overall, CPB2-AS1 is a protein that is involved in the development and progression of many types of cancer. As a result, it is a potential drug target for cancer researchers to target in order to develop new and more effective treatments for these diseases.

Protein Name: CPB2 Antisense RNA 1

The "CPB2-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CPB2-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets